[1]
Km. Bhumika et al. 2025. Enhanced Bioavailability and Targeted Delivery of Mesalamine for Crohn’s Disease Using Microemulsion Formulations. International Journal of Health Sciences and Engineering. 1, 1 (Feb. 2025), 16–20. DOI:https://doi.org/10.62896/v1.i1.03.